Table 5.

Top 50 predicted miRNAs associated with prostatic neoplasms based on known associations in HMDD

Rank	miRNA	Evidence	Rank	miRNA	Evidence
1	hsa-mir-155	I; II	26	hsa-mir-196a-2	I; II
2	hsa-mir-18a	I; II	27	hsa-mir-429	Unconfirmed
3	hsa-mir-19a	I; II	28	hsa-mir-199b	I; II; III
4	hsa-mir-19b-1	I; II; III	29	hsa-mir-181b-2	I; II; III
5	hsa-let-7a-3	I; II; III	30	hsa-mir-150	I; II
6	hsa-let-7a-2	I; II; III	31	hsa-mir-138-2	II
7	hsa-mir-29c	I; II; IV	32	hsa-mir-138-1	II
8	hsa-mir-9-1	I; II	33	hsa-mir-125a	I; II; III
9	hsa-mir-181a-1	I; II; III	34	hsa-mir-24-1	I; II; III
10	hsa-mir-210	I; II; III	35	hsa-mir-30a	I; II; III
11	hsa-mir-7-1	I; II; IV	36	hsa-mir-196a-1	I; II
12	hsa-mir-181a-2	I; II	37	hsa-mir-192	I
13	hsa-mir-9-2	I; II	38	hsa-mir-302b	I; II
14	hsa-mir-9-3	I; II	39	hsa-mir-451a	I
15	hsa-mir-10b	I; II; III	40	hsa-mir-103a-2	I
16	hsa-mir-7-2	I; II; IV	41	hsa-mir-302a	I; II; IV
17	hsa-mir-142	I; II	42	hsa-mir-20b	I
18	hsa-let-7f-2	I; II; III	43	hsa-mir-18b	I
19	hsa-let-7i	I; II	44	hsa-mir-10a	I; II; III
20	hsa-let-7e	I; II	45	hsa-mir-302c	I; II
21	hsa-let-7 g	I; II; III	46	hsa-mir-24-2	I; II; III
22	hsa-mir-7-3	I; II; IV	47	hsa-mir-137	II
23	hsa-let-7f-1	I; II; III	48	hsa-mir-206	I; II
24	hsa-mir-218-2	I; II; III	49	hsa-mir-149	I; II; III
25	hsa-mir-19b-2	I; II; III	50	hsa-mir-135a-1	I; II; IV

I, II, III and IV represent dbDEMC, PhenomiR, miR2Disease and miRwayDB, respectively